Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Enliven Therapeutics
ELVN
$4.15B
| $479K | ﹤0.01% |
23,900
+12,000
| +101% | +$227K |
|
2852
Portland General Electric
POR
$5.9B
| $479K | ﹤0.01% |
11,800
-197,819
| -94% | -$8.3M |
|
2853
JPMorgan BetaBuilders Europe ETF
BBEU
$9.39B
| $479K | ﹤0.01% |
7,100
-11,000
| -61% | -$711K |
|
2854
Superior Group of Companies
SGC
$202M
| $478K | ﹤0.01% |
46,400
+1,300
| +3% | +$13.2K |
|
|
RPT
2855
Rithm Property Trust
RPT
$95.1M
| $477K | ﹤0.01% |
29,461
+3,503
| +13% | +$57K |
|
2856
Invesco S&P SmallCap Momentum ETF
XSMO
$3.09B
| $476K | ﹤0.01% |
+7,000
| New | +$446K |
|
2857
Invesco Solar ETF
TAN
$1.45B
| $475K | ﹤0.01% |
+13,874
| New | +$436K |
|
2858
Assurant
AIZ
$14B
| $474K | ﹤0.01% |
2,400
-22,141
| -90% | -$4.35M |
|
2859
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.35B
| $473K | ﹤0.01% |
+14,500
| New | +$430K |
|
|
SVC
2860
Service Properties Trust
SVC
$1.02B
| $473K | ﹤0.01% |
39,600
-103,460
| -72% | -$1.12M |
|
2861
ProShares Ultra Bitcoin ETF
BITU
$347M
| $471K | ﹤0.01% |
+9,100
| New | +$414K |
|
2862
Prelude Therapeutics
PRLD
$350M
| $471K | ﹤0.01% |
581,800
-74,900
| -11% | -$64.9K |
|
2863
Ohio Valley Banc Corp
OVBC
$201M
| $470K | ﹤0.01% |
14,575
+800
| +6% | +$26.5K |
|
2864
Vanguard Russell 1000 Growth ETF
VONG
$43.7B
| $470K | ﹤0.01% |
+4,300
| New | +$423K |
|
|
ITRM
2865
DELISTED
Iterum Therapeutics
ITRM
| $470K | ﹤0.01% |
471,900
+231,000
| +96% | +$241K |
|
2866
Gen Digital
GEN
$16.9B
| $469K | ﹤0.01% |
+15,938
| New | +$436K |
|
2867
Perfect Corp
PERF
$197M
| $468K | ﹤0.01% |
203,695
-34,405
| -14% | -$63.5K |
|
|
KG
2868
Kestrel Group
KG
$66.7M
| $468K | ﹤0.01% |
17,648
-1,823
| -9% | -$42.2K |
|
2869
Calumet Specialty Products
CLMT
$3.69B
| $466K | ﹤0.01% |
+29,600
| New | +$376K |
|
2870
Tenable Holdings
TENB
$3.86B
| $466K | ﹤0.01% |
+13,800
| New | +$448K |
|
2871
Direxion Daily TSLA Bear 1X ETF
TSLS
$79.6M
| $465K | ﹤0.01% |
+5,930
| New | +$528K |
|
|
BNT
2872
Brookfield Wealth Solutions
BNT
$12B
| $463K | ﹤0.01% |
11,250
-2,100
| -16% | -$77.8K |
|
2873
Spyre Therapeutics
SYRE
$8.24B
| $463K | ﹤0.01% |
+30,936
| New | +$458K |
|
2874
Value Line
VALU
$342M
| $462K | ﹤0.01% |
11,800
+600
| +5% | +$23.5K |
|
2875
KB Home
KBH
$3.45B
| $461K | ﹤0.01% |
8,700
-325,800
| -97% | -$17.3M |
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.